It was also suggested that IL-1β inhibition could represent a broad-acting and efficacious method for managing pain and inflammation across various conditions such as gout, rheumatoid arthritis, or neuropathic pain [28]. This evidence concerns the gene IL1B and rheumatoid arthritis.